Sex: F
Vaccine: COVID19
Symptoms: Contusion, Haemorrhage, Pain, Skin discolouration, Wrong technique in product usage process
Clinical narrative: Patient experienced bleeding; Patient experienced bruises; blue line appeared; Patient experienced pain; vaccinator used a terrible horrendous technique to administer the vaccine /A tourniquet was made on the patient for the vaccination process; This spontaneous case was reported by a patient and describes the occurrence of HAEMORRHAGE (Patient experienced bleeding) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccinator used a terrible horrendous technique to administer the vaccine /A tourniquet was made on the patient for the vaccination process). On an unknown date, the patient experienced HAEMORRHAGE (Patient experienced bleeding) (seriousness criterion medically significant), CONTUSION (Patient experienced bruises), SKIN DISCOLOURATION (blue line appeared) and PAIN (Patient experienced pain). At the time of the report, HAEMORRHAGE (Patient experienced bleeding), CONTUSION (Patient experienced bruises) and PAIN (Patient experienced pain) had not resolved and SKIN DISCOLOURATION (blue line appeared) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (vaccinator used a terrible horrendous technique to administer the vaccine /A tourniquet was made on the patient for the vaccination process) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant drug reported. Patient experienced bruises, bleeding, pain and 7 days later it was worse and a blue line appeared. A tourniquet was made on the patient for the vaccination process. No treatment information was provided by the reporter.  Company comment: This spontaneous case reported by a consumer concerns a female patient of unknown age with no reported medical history, who experienced the unexpected serious (medically significant) event of Haemorrhage, which occurred unknown days after receiving first dose of mRNA-1273 Vaccine. As per the patient vaccinator used a terrible horrendous technique to administer the vaccine'. The exact site and nature of bleeding, clinical course, investigations and treatment has not been reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per Medical judgement.   This case was linked to MOD-2022-573629, MOD-2021-025166 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-May-2022: Significant follow up received, case made valid by adding new events are added. Vaccine indication corrected. narrative updated,; Sender's Comments: This spontaneous case reported by a consumer concerns a female patient of unknown age with no reported medical history, who experienced the unexpected serious (medically significant) event of Haemorrhage, which occurred unknown days after receiving first dose of mRNA-1273 Vaccine. As per the patient vaccinator used a terrible horrendous technique to administer the vaccine'. The exact site and nature of bleeding, clinical course, investigations and treatment has not been reported. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per Medical judgement.